In a family of individuals with mutations in GATA4, 46,XY DSD and congenital heart disease, AMH levels were consistently low and functional analysis demonstrated that mutations in GATA4 may reduce the action of the AMH promoter (74). This evidence concerns the gene GATA4 and congenital heart disease.